261 results on '"Stephens, Camilla"'
Search Results
2. Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case–control study
3. Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans
4. Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) Network
5. Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries
6. Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate
7. TOP-350-YI DNA differential methylation as a potential drug-induced liver injury biomarker and genome-wide DNA methylation functional analysis
8. OS-067 Specific metabolomic and bile acid profiles and their relationship with gut microbiota composition in patients with drug-induced liver injury
9. Serious liver injury induced by Nimesulide: an international collaborative study
10. Drug-induced liver injury in older people
11. Genetic Predisposition to Drug-Induced Liver Injury
12. Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries
13. Drug induced liver injury: an update
14. High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries
15. OP-1 FEATURES OF IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI) IN LATIN AMERICA: LONG-TERM EXPERIENCE OF THE LATINDILI NETWORK
16. Epigenetic modifications implicated in idiosincratic drug-induced liver injury
17. Altered intestinal permeability in patients with drug-induced liver injury and other forms of acute liver injury: a sequential analysis of serum levels of LBP, CD14 and CD163
18. Cook with the season.
19. A new framework for advancing in drug‐induced liver injury research. The Prospective European <scp>DILI</scp> Registry
20. Drug-Induced Liver Disease: Mechanism and Diagnosis
21. TEN A DAY.
22. Meat-free MEALS.
23. Evaluation of diagnostic and prognostic candidate biomarkers in drug‐induced liver injury vs . other forms of acute liver damage
24. Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case–control study
25. A new framework for advancing in drug-induced liver injury research: The Prospective European DILI Registry
26. Host Risk Modifiers in Idiosyncratic Drug-Induced Liver Injury (DILI) and Its Interplay with Drug Properties
27. Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries
28. A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry
29. A new framework for advancing in Drug-Induced Liver Injury research. The Prospective European DILI Registry
30. Identification of New Toxicity Mechanisms in Drug-Induced Liver Injury through Systems Pharmacology
31. Elevated levels of circulating CDH5 and FABP1 in association with human drug‐induced liver injury
32. Demethylation of oligogalacturonides by FaPE1 in the fruits of the wild strawberry Fragaria vesca triggers metabolic and transcriptional changes associated with defence and development of the fruit
33. Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases
34. A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry.
35. O-2 ROLE OF IMMUNE CHECKPOINTS AND ACTIVATED HELPER AND CYTOTOXIC T-CELLS IN DRUG-INDUCED LIVER INJURY (DILI)
36. Lymphocyte Profile and Immune Checkpoint Expression in Drug‐Induced Liver Injury: An Immunophenotyping Study
37. P041 Tandem mass tag-based quantitative proteomic profiling identifies novel putative serum biomarkers for the diagnosis of drug-induced liver injury in patients
38. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
39. Serious liver injury induced by Nimesulide: an international collaboration study reporting 57 cases
40. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
41. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
42. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
43. Characterizing Highly Cited Papers in Mass Cytometry through H-Classics
44. FRI-406 - Altered intestinal permeability in patients with drug-induced liver injury and other forms of acute liver injury: a sequential analysis of serum levels of LBP, CD14 and CD163
45. TOP-087 - Epigenetic modifications implicated in idiosincratic drug-induced liver injury
46. List of Contributors
47. Causality Assessment
48. Altered fungal sensitivity to a plant antimicrobial peptide through over-expression of yeast cDNAs
49. Genetic risk factors in the development of idiosyncratic drug-induced liver injury
50. Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injury
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.